Record Business Insider: FIRM's VACCINE BOOST
Posted on: Friday, 5 August 2005, 06:00 CDT
A NEW vaccine that could offer lifetime protection against all types of flu is being developed by UK biotech firm Acambis. Cambridge-based Acambis said the vaccine would end the need for people to have flu jabs each year and may also protect them againstany virulent new strains that emerge, such as bird flu
. Shares in Acambis, who are best known for developing the smallpox vaccine ACAM2000, rose three per cent yesterdaySource: Daily Record; Glasgow (UK)
Related Articles
- Universal Flu Vaccine Now in Human Trials
- Experimental Flu Vaccine Bypasses Needles
- Flu Vaccine Failure Spotlights Faulty System
- Flu Vaccine Supply Cut in Half
- U.S. Flu Vaccine Supply Cut in Half
- Tainted Flu Vaccine May Cause Delay
- FDA Warns Public to Beware of Illegal Flu Vaccine
- U.S. Buys More Flu Vaccine as Outbreak Widens
- Flu Vaccine's Strength Worries Experts
- Flu Vaccine Likely to Be Not As Potent
User Comments (0)

RSS Feeds